Evidence map›Paper›PMID 38957501›Full record

ArticlePublic health action2024

Perception, acceptability and challenges of digital adherence technology among TB healthcare workers.

I Gordon, B Odume, C Ogbudebe, O Chukwuogo, N Nwokoye, S Useni, E Efo, M Gidado, E Aniwada, A Ihesie and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health action, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

I GordonKNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria.
B OdumeKNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria.
C OgbudebeKNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria.
O ChukwuogoKNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria.
N NwokoyeKNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria.
S UseniKNCV Tuberculosis Foundation Nigeria, Abuja, Nigeria.
E EfoKNCV TB Plus, The Hague, Netherlands.
M GidadoKNCV TB Plus, The Hague, Netherlands.
E AniwadaDepartment of Community Medicine, University of Nigeria Teaching Hospital, Enugu.
A IhesieUnited States Agency for International Development (USAID), Abuja.
D NongoUnited States Agency for International Development (USAID), Abuja.
R EneoguUnited States Agency for International Development (USAID), Abuja.
O Chijioke-AkaniroNational Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.
C AnyaikeNational Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSuccessful treatment of TB requires high levels of adherence to treatment. This has been found to be below optimal with directly observed therapy (DOT), and digital adherence technologies (DATs) offer a promising approach to non-adherence to medication and improving treatment outcomes. This study explores the perception, acceptability, and challenges of DATs among healthcare workers (HCWs).

methodsThe study was conducted in eight states in Nigeria among Health Care workers involved in treating patients with TB. This was a descriptive cross-sectional study using an open questionnaire and analysed using IBM SPSS v25.

resultsTwenty-three HCWs (95.8%) agreed that DATs helped them provide better support and counselling to their patients. All of them would recommend DATs to their patients and found it easy to explain them. Eleven (45.8%) of them were not able to use DATs on a few occasions; their reasons were poor network (

conclusionDATs help HCWs provide better support and care regarding real-time tracking of their patients' adherence to treatment and possibly reduction of attrition. This implies that DATs are a suitable alternative to DOT to help HCWs provide the best care and support to their patients towards achieving the End TB targets.

Indexed as

DATHCWsNigeriatuberculosis

Identifiers

PMID38957501
PMCPMC11216288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.